Showing results (1-10 of 155) with videos related to
Sort By:
Pageof 16
Frontiers in Psychiatry|September 7, 2021
Quantifying the Impact of Phenoconversion on Medications With Actionable Pharmacogenomic Guideline Recommendations in an Acute Aged Persons Mental Health SettingSam Mostafa, Thomas M Polasek, Leslie J Sheffield, et al.Clinical Pharmacology and Therapeutics|May 7, 2026
A Review of Virtual Twins in Physiologically-Based Pharmacokinetic Modeling and SimulationEmily Mannix, Sam Mostafa, Amin Rostami-Hodjegan, et al.Therapeutic Advances in Drug Safety|December 20, 2019
Precision dosing to avoid adverse drug reactionsThomas M Polasek, Carl M J Kirkpatrick, Amin Rostami-HodjeganCPT: Pharmacometrics & Systems Pharmacology|November 25, 2022
Delineating gene-environment effects using virtual twins of patients treated with clozapineSam Mostafa, Thomas M Polasek, Chad Bousman, et al.CPT: Pharmacometrics & Systems Pharmacology|January 20, 2024
Virtual twins for model-informed precision dosing of clozapine in patients with treatment-resistant schizophreniaSam Mostafa, Reza Rafizadeh, Thomas M Polasek, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|September 8, 2018
An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genesSam Mostafa, Carl M J Kirkpatrick, Keith Byron, et al.Pharmacogenomics|September 28, 2022
Pharmacogenomics in psychiatry - the challenge of cytochrome P450 enzyme phenoconversion and solutions to assist precision dosingSam Mostafa, Thomas M Polasek, Chad A Bousman, et al.Frontiers in Genetics|May 22, 2023
Calculation of the pharmacogenomics benefit score for patients with medication-related problemsThomas M PolasekExpert Review of Clinical Pharmacology|February 2, 2024
Pharmacogenomics - a minor rather than major force in clinical medicineThomas M PolasekPageof 16